Antiretroviral protease inhibitors containing HIV aspartyl protease inhibitors could increase CD4 cell count [18] and inhibited the fungal secretory aspartyl proteinases, thus leading to reduced Candida infection during mucosal invasion [17]. Here, CD4 is linked to candidiasis.